Drug resistance in cancer: mechanisms and tackling strategies

T Haider, V Pandey, N Banjare, PN Gupta… - Pharmacological …, 2020 - Springer
Drug resistance developed towards conventional therapy is one of the important reasons for
chemotherapy failure in cancer. The various underlying mechanism for drug resistance …

Reactive oxygen species induced p53 activation: DNA damage, redox signaling, or both?

T Shi, TB Dansen - Antioxidants & Redox Signaling, 2020 - liebertpub.com
Significance: The p53 tumor suppressor has been dubbed the “guardian of genome”
because of its various roles in the response to DNA damage such as DNA damage repair …

To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response

Q Liu, J Gao, C Zhao, Y Guo, S Wang, F Shen, X Xing… - DNA repair, 2020 - Elsevier
Abstract CDK2 (cyclin-dependent kinase 2), a member of the CDK family, has been shown
to play a role in many cellular activities including cell cycle progression, apoptosis and …

Prognostic value of DNA damage response genomic alterations in relapsed/advanced urothelial cancer

M Yin, P Grivas, QE Wang, A Mortazavi… - The …, 2020 - academic.oup.com
Background DNA damage response (DDR) genomic alterations may play an important role
in clinical outcomes of patients with urothelial cancer (UC). However, data on the prognostic …

Therapeutic targeting of the DNA damage response in prostate cancer

CH Marshall, ES Antonarakis - Current opinion in oncology, 2020 - journals.lww.com
Therapeutic targeting of the DNA damage response in prostate... : Current Opinion in Oncology
Therapeutic targeting of the DNA damage response in prostate cancer : Current Opinion in …

[HTML][HTML] Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

J Fan, Y Zhao, H Yuan, J Yang, T Li, Z He… - American journal of …, 2020 - ncbi.nlm.nih.gov
Whole human genome microarray was performed to identify the potential molecular
mechanisms associated with phospholipase C epsilon (PLCε). Gene Ontology, Kyoto …

[HTML][HTML] A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib

G Chen, K Hu, H Sun, J Zhou, D Song, Z Xu, L Gao… - Cancer Letters, 2020 - Elsevier
Multiple myeloma (MM) is an incurable hematological malignancy, for which novel effective
therapies are urgently needed. We synthesized a novel phosphoramide compound …

Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics

A Bensimon, JP Koch, P Francica, SM Roth… - Molecular …, 2020 - Wiley Online Library
Increasing evidence suggests that interference with growth factor receptor tyrosine kinase
(RTK) signaling can affect DNA damage response (DDR) networks, with a consequent …

[HTML][HTML] Pharmacological evaluation and mechanistic study of compound Xishu Granule in hepatocellular carcinoma

P Li, Y Shi, B Zhao, W Xu, Z Xu, J Zhang, Z Guo… - Journal of Traditional …, 2020 - Elsevier
Objective In this study, we used HepG2 human hepatocellular carcinoma cells to study the
effects of Compound Xishu Granule (CXG) on cell proliferation, apoptosis, and the cell cycle …

Effect of carbogen to chemoradiation in volume of rectal cancer

CH Nawangsih, S Gondhowiardjo… - Acta Medica …, 2020 - publish.kne-publishing.com
The outcome of inoperable rectal cancer treatment by chemotherapy, radiotherapy, and
targeted therapy are still unfavorable. Carbogen is a combination of 98% oxygen and 2 …